Clinical Trials Directory

Trials / Unknown

UnknownNCT03466645

The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Surgical-site infection is the most commonly reported nosocomial infection in patients undergoing surgery and 3rd most nosocomial infection in hospitalized patients. The SSI is associated with increases of length of hospitalization for 6 days and increases the hospital's cost by $ 300. Because of these, prevention of SSI with appropriate antibiotic is essential.

Conditions

Interventions

TypeNameDescription
DRUGVancomycinThe 1st group receives vancomycin an hour before craniotomy
DRUGCefazolinThe 2nd group receives cefazolin an hour before craniotomy

Timeline

Start date
2018-04-01
Primary completion
2019-04-01
Completion
2019-08-01
First posted
2018-03-15
Last updated
2018-03-15

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT03466645. Inclusion in this directory is not an endorsement.

The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy (NCT03466645) · Clinical Trials Directory